Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older at the time of signing the consent form
- You have been diagnosed with Systemic Lupus Erythematosus (SLE, a type of autoimmune disease)
- Your doctor has prescribed you a medication called anifrolumab (given as an injection under the skin), following the approved guidelines for its use in Europe
- Your doctor decided to prescribe this medication before and separately from this study — meaning the study did not influence your treatment decision
- You are willing and able to take part in all study visits and procedures over the study period
- You have signed and dated a consent form before joining the study
Who may not be able to join:
- You have previously used anifrolumab at any point
- You are currently being treated with other biologic medications (a certain type of advanced drug treatment)
- You are already taking part in, or planning to join, another clinical trial that goes beyond your usual routine care
- You currently have a severe, fast-worsening form of lupus affecting the kidneys (certain specific types), or severe and unstable lupus affecting the brain or mental health, that requires intensive treatment (confirm with trial site)
- Your doctor feels that a current health condition — such as significant memory or thinking problems, severe unstable mental illness, or uncontrolled alcohol or substance use — would prevent you from completing questionnaires or attending visits regularly over 24 months
- You are pregnant or breastfeeding at the time of joining the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion and number of patients who fulfill criteria for definition of remission in SLE (DORIS remission)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.